CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 283 enrolled / 283 target
Drug / intervention
Non-interventional Cross-sectional Patient Reported Outcome Measure Developmentother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05086900
NCT05086900N/ACompletedHigh Momentum (4.6/mo)Completion was 57mo ago

Developing a Patient Reported Outcome Measure for Recurrent Urinary Tract Infection

University of Reading·observational·Posted Oct 21, 2021·Updated Jun 11, 2026

In Brief

An observational study evaluating Non-interventional Cross-sectional Patient Reported Outcome Measure Development for Urologic Diseases and 3 related conditions. Completed, enrolled 283 participants across 1 site.

Signals

Enrolling ahead of pace

Detailed Summary

This study aims to develop and validate the first set of patient-reported outcome measures for recurrent urinary tract infection (UTI): the Recurrent UTI Symptom Scale and the Recurrent UTI Impact Questionnaire. These tools could be used in clinical practice, clinical trials and research to gather an insight into a patient's perspective of their recurrent UTI symptom severity and its impact on their life, as well as determining any possible improvement or other change in their condition due to interventions (e.g. antibiotic treatment).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom
CollaboratorsLive UTI Free

Timeline

N/ACompletedFinished
20222023202420252026
First PostedOct 21, 2021
Enrollment StartMay 1, 2021
Primary CompletionSep 1, 2021
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 4.7 years ago

Interventions

Non-interventional Cross-sectional Patient Reported Outcome Measure Developmentother

Development of Patient Reported Outcome Measure